Hikma Pharmaceuticals PLC:企業のM&A・事業提携・投資動向

◆英語タイトル:Hikma Pharmaceuticals PLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C2080
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:119
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Hikma Pharmaceuticals PLC – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Hikma Pharmaceuticals PLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Hikma Pharmaceuticals PLC since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Hikma Pharmaceuticals PLC’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Hikma Pharmaceuticals PLC. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Hikma Pharmaceuticals PLC’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Hikma Pharmaceuticals PLC and its subsidiaries since 2007.
- Information about key financial and legal advisors for Hikma Pharmaceuticals PLC’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Hikma Pharmaceuticals PLC’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 6
LIST OF FIGURES 6
TARGETS AND PARTNERS 7
MERGERS & ACQUISITIONS 8
Mergers and Acquisitions – Overview 8
Mergers and Acquisitions – Deal reports 9
CORPORATE VENTURING 64
Corporate Venturing – Deal reports 64
PARTNERSHIP 66
Partnership – Overview 66
Partnership – Deal reports 67
DIVESTMENTS 106
Divestments – Overview 106
Divestments – Deal reports 107
APPENDIX 109
Contact Us 109
About MarketLine Financial Deals Database 109
Deal Definition and Methodology 111
About MarketLine 118

List of Tables
Table 1: Hikma Pharmaceuticals PLC M&A volume and value trend (2014-YTD2018)
Table 2: Hikma Pharmaceuticals PLC M&A activity by geography (2014-YTD2018)
Table 3: Hikma Pharmaceuticals PLC partnership volume and value trend (2014-YTD2018)
Table 4: Hikma Pharmaceuticals PLC partnership trend by key deal type (2014-YTD2018)
Table 5: Hikma Pharmaceuticals PLC divestments volume and value trend (2014-YTD2018)
Table 6: Hikma Pharmaceuticals PLC divestments activity by geography (2014-YTD2018)

List of Figures
Figure 1: Hikma Pharmaceuticals PLC M&A volume and value trend (2014-YTD2018)
Figure 2: Hikma Pharmaceuticals PLC M&A activity by geography (2014-YTD2018)
Figure 3: Hikma Pharmaceuticals PLC partnership volume and value trend (2014-YTD2018)
Figure 4: Hikma Pharmaceuticals PLC partnership trend by key deal type (2014-YTD2018)
Figure 5: Hikma Pharmaceuticals PLC divestments volume and value trend (2014-YTD2018)
Figure 6: Hikma Pharmaceuticals PLC divestments by geography (2014-YTD2018)

★海外企業調査レポート[Hikma Pharmaceuticals PLC:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Jubilee Life Insurance Company Limited:企業の戦略・SWOT・財務情報
    Jubilee Life Insurance Company Limited - Strategy, SWOT and Corporate Finance Report Summary Jubilee Life Insurance Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • BearingPoint:企業の戦略的SWOT分析
    BearingPoint - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Tencent Holdings Limited:企業のM&A・事業提携・投資動向
    Tencent Holdings Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Tencent Holdings Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • BNRG Renewables Ltd:電力:M&Aディール及び事業提携情報
    Summary BNRG Renewables Ltd (BNRG) is a renewable energy company that develops, finance and constructs ground mounted and rooftop solar photovoltaic projects. The company offers services such as project management, site assessment, planning and grid connection, asset management, and construction man …
  • Tenaris SA:戦略・SWOT・企業財務分析
    Tenaris SA - Strategy, SWOT and Corporate Finance Report Summary Tenaris SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Interconexion Electrica SA ESP (ISA):企業の財務・戦略的SWOT分析
    Interconexion Electrica SA ESP (ISA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Volkswagen AG (VOW3):企業の財務・戦略的SWOT分析
    Volkswagen AG (VOW3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Becton Dickinson and Co (BDX):企業の財務・戦略的SWOT分析
    Becton Dickinson and Co (BDX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • MBDA Holdings SAS:企業の戦略・SWOT・財務情報
    MBDA Holdings SAS - Strategy, SWOT and Corporate Finance Report Summary MBDA Holdings SAS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Instrumentation Laboratory Company:企業の製品パイプライン分析2018
    Summary Instrumentation Laboratory Company (IL), a subsidiary of Werfen Life Group, is a medical device company with focus on in vitro diagnostics (IVD) devices. The company develops, manufactures, and distributes IVD instruments, related reagents and controls for hospitals and clinical laboratories …
  • Sienna Biopharmaceuticals Inc (SNNA):製薬・医療:M&Aディール及び事業提携情報
    Summary Sienna Biopharmaceuticals Inc (Sienna Biopharmaceuticals) is a clinical-stage biopharmaceutical company that develops and commercializes topical products in medical dermatology and aesthetics. Through its topical photoparticle therapy platform, the company advanced its product SNA-001, into …
  • Multan Electric Power Company:企業の戦略的SWOT分析
    Multan Electric Power Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Tetra Technologies, Inc.:企業の戦略・SWOT・財務分析
    Tetra Technologies, Inc. - Strategy, SWOT and Corporate Finance Report Summary Tetra Technologies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Fluxion Biosciences Inc:医療機器:M&Aディール及び事業提携情報
    Summary Fluxion Biosciences Inc (Fluxion) is a provider of analytical instruments for functional cellular analyses. The company’s liquid biopsy technologies include IsoFlux CTC liquid biopsy system, ERASE-Seq variant caller for liquid biopsies and the Spotlight 59 for ultra-sensitive NGS mutation de …
  • D. Western Therapeutics Institute Inc (4576):製薬・医療:M&Aディール及び事業提携情報
    Summary D. Western Therapeutics Institute Inc (DWTI) is a pharmaceutical product s developer. The company offers ophthalmic solution, WP-1303, H-1337, K-134 and DW-1002. It discovers and develops drugs for glaucoma. DWTI’s ophthalmic solution treats glaucoma and ocular hypertension treatment and art …
  • Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (874):企業の財務・戦略的SWOT分析
    Summary Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (Guangzhou Baiyunshan Pharmaceutical) is a manufacturer of herbal medicine, chemical raw material medicine and preparation, biological medicine, and health products. The company also offers herbal tea, Chinese and Western medicine, intermed …
  • INEOS Olefins & Polymers Europe:企業の戦略的SWOT分析
    INEOS Olefins & Polymers Europe - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Bob Evans Farms, Inc.:企業の戦略・SWOT・財務情報
    Bob Evans Farms, Inc. - Strategy, SWOT and Corporate Finance Report Summary Bob Evans Farms, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Jupiter Energy Ltd (JPR):石油・ガス:M&Aディール及び事業提携情報
    Summary Jupiter Energy Ltd (Jupiter Energy) is an oil exploration and production company that carries out acquisition, exploration, production, and develops oil and natural gas properties. The company holds an exploration permit in the oil-rich Mangistau Basin in West Kazakhstan. It also holds inter …
  • Evonik Industries AG (EVK):製薬・医療:M&Aディール及び事業提携情報
    Summary Evonik Industries AG (Evonik), a subsidiary of RAG-Stiftung, is a specialty chemicals company. Its product portfolio includes surfactants, polymers, resins, additives and others. The company’s products find application in various markets, including adhesives and sealants, automotive, agricul …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆